COVID-19: INFO for NIH Applicants on NIH Funding

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding

https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

The NIH is deeply concerned for the health and safety of people involved in NIH research, and about the effects on the biomedical enterprise in the areas affected by the HHS declared public health emergency for COVID-19. Due to the potential exceptional impact, we want to assure our recipient community that NIH will be doing our part to help you continue your research.

This notice provides updated Guidance on:

·         Proposal Submission & Award Management

UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-091

General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 - NOT-OD-20-083

Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 - NOT-OD-20-086

Human Subjects & Clinical Trials

Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 - NOT-OD-20-087

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic 

·         Animal Welfare

OLAW Webinar: Pandemic Contingency Planning and Its Impact on Animal Care  - March 19, 2020 

Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 - NOT-OD-20-088

·         Peer Review

Based on NIH Guidance on Travel and Meetings , in-person NIH peer review meetings are being held in alternate formats. Scientific review officers will be in contact with peer reviewers about these changes.

·         FAQ’s

NIH FAQs: COVID-19 Flexibilities for Applicants and Recipients

·         Funding Opportunities Specific to COVID-19

               https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

 

Should you have any questions, please contact OSP.